SEC Filing Summary: BioSig Technologies, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on July 14, 2020. The filing discloses the entry into a Material Definitive Agreement and a Material Modification to the Rights of Security Holders. The Company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial statements are included in this document.
Material Changes and Corporate Actions
- Adoption of Poison Pill: The Board declared a dividend of one Right for each outstanding share of Common Stock, payable to stockholders of record on July 27, 2020.
- Trigger Threshold: Rights become exercisable if an "Acquiring Person" acquires 12% or more of the outstanding Common Stock or initiates a tender offer resulting in such ownership.
- Flip-In Mechanism: Upon triggering, holders (excluding the Acquiring Person) may purchase 1/1000th of a share of Series F Junior Participating Preferred Stock at $50.00 per Right. Alternatively, holders may receive Common Stock with a value equal to two times the Purchase Price.
- Preferred Stock Rights: The Series F Preferred Stock carries significant voting power (1,000 votes per share) and preferential dividend rights.
- Expiration: The Rights Agreement expires on the earliest of July 13, 2021, redemption by the Board, or a merger/acquisition approved by the Board prior to a triggering event.
- Redemption: The Board may redeem the Rights in whole at $0.001 per Right at any time before an Acquiring Person emerges.
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance or management commentary on operational outlook. The primary purpose is to implement a defensive measure against unsolicited takeover attempts. The filing notes that the Rights Agreement may be amended by the Board without stockholder approval, provided such amendments do not adversely affect the interests of non-acquiring holders.
Investor Verification Checklist
- Verify the Record Date of July 27, 2020, to determine eligibility for the Rights dividend.
- Confirm the 12% ownership threshold that triggers the Rights Plan.
- Review the Redemption Price of $0.001 per Right to understand the Board's ability to nullify the plan.
- Examine the Series F Preferred Stock designations for voting and dividend preferences.
- Note the Expiration Date of July 13, 2021, unless the plan is redeemed or a transaction occurs earlier.